Showing results (1101-1110 of 1,129) with videos related to

Sort By:
Pageof 113
Experimental Hematology & Oncology|July 9, 2025
Reduced morbidity and mortality of cGVHD in patients who received treatment with mesenchymal stromal cells for steroid-resistant aGVHD: long-term follow-up of a randomized phase 3 trialKe Zhao, Ren Lin, Zhiping Fan, et al.
Plant Biotechnology Journal|October 5, 2022
Time-ordering japonica/geng genomes analysis indicates the importance of large structural variants in rice breedingYu Wang, Fengcheng Li, Fan Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2022
Busulfan Plus Cyclophosphamide Versus Total Body Irradiation Plus Cyclophosphamide for Adults Acute B Lymphoblastic Leukemia: An Open-Label, Multicenter, Phase III TrialHaiyan Zhang, Zhiping Fan, Fen Huang, et al.
Oncology and Therapy|December 16, 2023
Patient Versus Physician Perspective in the Management of Chronic Myeloid Leukemia During Treatment with Tyrosine Kinase InhibitorsHong Chen, Yan Wen, Yun Zeng, et al.
JAMA Network Open|July 7, 2021
Association Between Measurable Residual Disease in Patients With Intermediate-Risk Acute Myeloid Leukemia and First Remission, Treatment, and OutcomesSijian Yu, Zhiping Fan, Liping Ma, et al.
Annals of Hematology|June 5, 2021
Adolescents experienced more treatment failure than children with chronic myeloid leukemia receiving imatinib as frontline therapy: a retrospective multicenter studyXuelin Dou, Fangyuan Zheng, Liqiang Zhang, et al.
Journal of Internal Medicine|October 29, 2023
Sorafenib plus triplet therapy with venetoclax, azacitidine and homoharringtonine for refractory/relapsed acute myeloid leukemia with FLT3-ITD: A multicenter phase 2 studySijian Yu, Yu Zhang, Guopan Yu, et al.
Frontiers in Immunology|November 4, 2021
β2-Adrenergic Receptor Enhances the Alternatively Activated Macrophages and Promotes Biliary Injuries Caused by Helminth InfectionStephane Koda, Beibei Zhang, Qian-Yang Zhou, et al.
Cell Reports|December 15, 2021
IFP35 as a promising biomarker and therapeutic target for the syndromes induced by SARS-CoV-2 or influenza virusYang Yu, Na Xu, Qi Cheng, et al.
Human Mutation|February 10, 2022
Genome sequencing demonstrates high diagnostic yield in children with undiagnosed global developmental delay/intellectual disability: A prospective studyYu Sun, Jing Peng, Desheng Liang, et al.
Pageof 113